Paul Ulanch
About Paul Ulanch
Paul Ulanch serves as the Senior Director of Focused Initiatives at the North Carolina Biotechnology Center, where he has held various leadership roles since 2011. He possesses a PhD in Biochemistry and an MBA, with a strong focus on technology commercialization and entrepreneurial ventures.
Work at North Carolina Biotechnology Center
Paul Ulanch has held multiple positions at the North Carolina Biotechnology Center (NCBiotech) since 2011. He served as the Ag Biotech Enterprise & Technology Development Director from 2011 to 2013. In 2013, he became the Executive Director of the Crop Commercialization Program, a role he has maintained for 11 years. In 2023, he transitioned to the position of Senior Director, Focused Initiatives. His work at NCBiotech focuses on advancing biotechnology initiatives and fostering commercialization strategies.
Education and Expertise
Paul Ulanch holds a Ph.D. in Biochemistry from Texas A&M University, where he studied from 1992 to 1999. He also earned an Executive MBA from the University of Pittsburgh Katz Graduate School of Business in 2005. Additionally, he has participated in an Executive Education Course on Design Thinking for Innovative Business Problem Solving at the University of Virginia since 2015. His educational background supports his expertise in technology commercialization and strategic management.
Background
Before his tenure at NCBiotech, Paul Ulanch worked at the North Carolina Small Business and Technology Development Center (NC SBTDC) as Director of Tech Commercialization Services from 2008 to 2011. He also served as a Technology Commercialization Counselor/Consultant at NC SBTDC from 2006 to 2011. His earlier experience includes a role as a Research Associate at the University of Pittsburgh School of Medicine from 2002 to 2004. His diverse background spans various roles in biotechnology and technology commercialization.
Achievements
Paul Ulanch is recognized as a thought leader in the biotechnology sector, having developed skills through numerous leadership responsibilities. His strong interest in entrepreneurial ventures and market strategy has contributed to his effectiveness in technology commercialization. He is also involved in stewardship initiatives, reflecting his commitment to advancing the biotechnology field and supporting innovation.